Medical neglect and refusal of care — formative SAQs

SAQ 1 — Definitions, the harm threshold and the four refusal scenarios (10 marks)

A 4-year-old boy is newly diagnosed with standard-risk acute lymphoblastic leukaemia. The cure rate with the standard chemotherapy protocol exceeds ninety per cent. His parents decline chemotherapy and tell you they will treat the cancer with herbal remedies and dietary changes. They are loving, attentive, and have no mental illness or access barriers — they simply believe the conventional treatment is harmful. [1] [9]

Questions

1. Define medical neglect and refusal of care, and state why this presentation is refusal of care rather than access-based medical neglect. (3 marks) [2] [3]
2. State the Diekema harm-principle threshold and apply its four conditions to this child. (4 marks) [1]
3. Outline your stepped management from the first conversation to the disposition if negotiation fails. (3 marks) [9] [12]

Model answer

Definitions and classification (3). Medical neglect is the failure of a caregiver, who has the responsibility and capacity to do so, to seek, attend to, or comply with medically necessary treatment for a child to a degree that causes or risks significant harm — a passive omission. Refusal of care is the active, deliberate rejection of recommended treatment on religious, ideological, or personal grounds. This family is refusal rather than access-based neglect because they understand the diagnosis and the treatment, face no poverty, transport, or health-literacy barrier, and have made an explicit, deliberate decision to reject the only effective therapy. The mechanism and the caregiving response separate the two; the label changes the response from support to negotiation and possible escalation. [2] [3]

The Diekema harm-principle threshold applied (4). Diekema proposed that the state should override parental refusal of medical treatment when four conditions are met: the child is at significant risk of serious harm; the harm is imminent; the recommended intervention is likely to be effective; and the burden of the intervention is proportionate. Applied here — first, the child is at significant risk of serious harm, because untreated acute lymphoblastic leukaemia is uniformly fatal. Second, the harm is imminent, because the treatment window for induction chemotherapy is narrow and the disease progresses within weeks. Third, the intervention is highly effective, with a cure rate exceeding ninety per cent. Fourth, the burden is proportionate, because the side effects of chemotherapy, though real, are time-limited and far outweighed by the alternative of death. All four conditions are met, and the threshold for legal intervention is crossed. [1]

Stepped management (3). Step 1 — recognise and assess harm: confirm the diagnosis and the prognosis, apply the harm threshold, and document the family's understanding. Step 2 — engage and negotiate: explore the family's specific fears, provide clear information about survival rates and side effects, involve the oncology team and a hospital ethicist, address misconceptions, and offer time — most families who initially refuse will accept treatment after negotiation, ethics consultation, and time. Step 3 — escalate if negotiation fails and the threshold is met: seek an urgent court order for treatment under parens patriae jurisdiction, make a mandatory child-protection report, and treat under the order while continuing to support the family. In an emergency, treat under the doctrine of necessity. Step 4 — follow up with a named clinical lead and return precautions, because the file is never closed on a single conversation. [9] [12]

SAQ 2 — Jehovah's Witness blood refusal, vitamin K refusal and the mature minor (10 marks)

A 6-year-old Jehovah's Witness girl presents to the emergency department after a motor-vehicle crash with acute blood loss and a haemoglobin of 45 g/L. Her parents refuse blood products on religious grounds. The surgical team estimates an urgent laparotomy is needed, and without blood the child is likely to die. Separately, in your newborn nursery, a family declines intramuscular vitamin K, and in your adolescent clinic a 15-year-old with newly diagnosed Hodgkin lymphoma refuses chemotherapy herself. [6] [8]

Questions

1. Outline your immediate management of the 6-year-old, including the legal and ethical basis for overriding the parental refusal of blood. (4 marks) [6]
2. State the risk of refusing neonatal vitamin K and your harm-reduction response. (3 marks) [8]
3. Assess whether the 15-year-old's refusal of chemotherapy can be respected, and how the threshold for overriding it differs from the adult threshold. (3 marks) [10]

Model answer

Jehovah's Witness blood refusal (4). The child faces imminent, life-threatening, preventable harm — all four Diekema conditions are met. I treat the emergency first: stabilise and resuscitate, and proceed to transfuse and operate under the doctrine of necessity if the child is in extremis and the court cannot be reached, because no child can consent to their own death. In parallel, I contact the hospital legal team and seek an urgent court order — courts in ANZ, the UK, the US, and Canada have consistently overridden parental refusal of blood transfusion for children on the basis that the child's right to life and best interests outweigh the parents' religious freedom. I explore blood-sparing strategies — cell salvage, acute normovolaemic haemodilution, erythropoietin — and respect the family's faith up to the harm threshold, but the threshold is crossed and I document the refusal, the information given, and the harm assessment verbatim. The negotiation runs alongside the resuscitation, never instead of it. [6]

Vitamin K refusal (3). Sahni showed that infants whose parents refuse intramuscular vitamin K are at risk of late vitamin K deficiency bleeding, which typically presents between two and twelve weeks of life as intracranial haemorrhage — a catastrophic, often fatal or neurologically devastating event that a single injection would have prevented. The harm threshold is met for the individual infant because the harm is significant, imminent within weeks, and preventable by an effective, low-burden intervention. My response is to provide clear information about the risk, offer oral vitamin K as harm reduction where the family will accept it — though oral regimens are less reliable and require multiple doses — document the refusal, and maintain vigilance for any bleeding presentation in the first months. Vitamin K refusal tracks alongside vaccine refusal, so I also revisit the immunisation plan. [8]

Mature minor refusal (3). Coleman and Rosoff established that competent adolescents may have the legal authority to consent to or refuse general medical treatment in many jurisdictions. I assess competence: does the young person understand the condition, the treatment, the consequences of refusal, and the alternatives? If competent, their refusal carries weight — but the threshold for overriding an adolescent's refusal of life-saving treatment is lower than for an adult. Courts weigh the young person's developing autonomy against the gravity and irreversibility of the harm, the presumption of future competence, and the fact that the adolescent has not yet had the chance to form mature values. For a 15-year-old refusing curative chemotherapy with a high cure rate, the irreversibility of death and the near-certainty of future competence weigh heavily toward intervention, and I involve ethics, legal, and mental-health teams to assess capacity and, if the refusal persists and the threshold is met, seek a court order. [10]